The direct-medical costs associated with interferon-based treatment for hepatitis C in Vietnam
<p><strong>Background:</strong><br> Injectable interferon-based therapies have been used to treat hepatitis C virus (HCV) infection since 1991. International guidelines have now moved away from interferon-based therapy towards direct-acting antiviral (DAA) tablet regimens, be...
Main Authors: | Nguyen, HA, Cooke, GS, Day, JN, Flower, B, Phuong, LT, Hung, TM, Dung, NT, Khoa, DB, Hung, LM, Kestelyn, E, Thwaites, GE, Chau, NVV, SEARCH Investigators, Turner, HC |
---|---|
Format: | Journal article |
Language: | English |
Published: |
F1000Research
2020
|
Similar Items
-
The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam [version 1; peer review: 2 approved]
by: Huyen Anh Nguyen, et al.
Published: (2019-09-01) -
The direct-medical costs associated with interferon-based treatment for Hepatitis C in Vietnam [version 2; peer review: 2 approved]
by: Huyen Anh Nguyen, et al.
Published: (2020-09-01) -
Proactive response and innovative approaches to SARS-CoV-2 in Vietnam
by: Chau, NVV, et al.
Published: (2021) -
Rapid whole-genome sequencing to inform COVID-19 outbreak response in Vietnam
by: Chau, NVV, et al.
Published: (2021) -
Wearable devices for remote monitoring of hospitalized patients with COVID-19 in Vietnam
by: Chau, NVV, et al.
Published: (2023)